The Scientific Committee of the 1st International Conference on Targeting Liver announces the preliminary program and list of speakers for June World Congress.

The Role of Specific Sphingolipids in Liver Diseases

Yael Pewzner-Jung, Weizmann Institute of Science, Rehovot, Israel

Diabetes and Liver: Recent Advances & Perspectives

Itamar Raz, Hadassah Ein Kerem Hospital,Jerusalem, Israel

Role of The Nitric Oxide Signaling in Cholesterol-Induced Liver Damage

Oren Tirosh, The Hebrew University of Jerusalem, Rehovot, Israel

MicroRNA in Liver Diseases: Recent Advances & Perspectives
Eithan Galun,
Hadassah Hebrew University Hospital, Jerusalem, Israel


The Role of NLG4 between Insulin Resistance and Innate Immunity in Fatty Liver Disease

Rifaat Safadi, Hadassah Medical Center, Jerusalem, Israel

Anti-Oxidants in Liver Disease: Recent Advances and Perspectives

Oren Shibolet, Hadassah-Hebrew University Medical Center,Jerusalem, Israel

Liver Repopulation Following Toxic Liver Injury - Which Genes Have Most Impact?

Klaus H. Kaestner, University of Pennsylvania School of Medicine, Philadelphia, USA

Stellate Cells in Hepatic Fibrogenesis and Protection by a Novel Modulator

Raj Lakshman, The George Washington University, Washington, USA

Interaction of Nutrition, Pouches, Microbiome and Oxidative Stress

Nitsan Maharshak, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel


Hepatic Paraoxonase-1 (PON1) Regulation: Recent Advances & Perspectives

Bianca Fuhrman, Technion Faculty of Medicine and Rambam Health Care Campus, Haifa, Israel

Mitochondria-Microbiota: The Intriguing Relationship
The future of medicine coming through bacteria
Marvin Edeas, Chairman of Targeting Mitochondria Task Force Group, Paris, France

Inflammation & NAFLD: Recent Advances & Perspectives

Ran Oren, Hadassah Medical Center, Jerusalem, Israel


Vitamin E & Diabetic Nephropathy: Lessons & Clinical Implications
Farid Nakhoul, Bar Iian University Ramat Gan, Lower Galilee, Israel


Obesity and Liver: Are Dietary Polyphenols Adipose Tissue Modulators?

Yishai Lévy, Rambam Health Care Campus, Bat Galim, Haifa, Israel


The Microbiome & Liver Diseases: Towards a New Understanding

Christoph Thaiss, Weizmann Institute of Science, Rehovot, Israel


Role of Lysophosphatidic Acid Receptor Dependent Signaling in Hepatic Tumor Cell Proliferation and Motility

Valentina Zuckerman, Carolinas Medical Center, Charlotte, USA


Converting Liver to Pancreas- Cell replacement therapy for Diabetes
Sarah Ferber, Sheba Medical Center, Tel-Hashomer, Israel

Biengineering Lives for Transplantation
Shay Soker, Institute for Regenerative Medicine, Winston-Salem, USA

SIRT1 Induction by P53 Inhibition Attenuates Hepatic Ischemia/Reperfusion Injury
Chung Hun Taeg, University of Ulsan, Ulsan, Korea

Human Cell Responses during Initial Steps of Hepatic Infection with Entamoeba Histolytica, the Etiological Agent of Amoebiasis
Daniela M. Faust,
Institut Pasteur, Paris, France

Role of Adiponectin in the Antisteatotic Effect of Cannabinoid-1 (Cb1) Receptor Blockade
Yossi Tam,
The Hebrew University of Jerusalem, Jerusalem, Israel

Mathematical Modeling of the Liver Metabolism under Normal and Pathophysiological Conditions
Hermann-Georg Holzhütter, Charité – Universitätsmedizin, Berlin, Germany

Protection Exerted by levosimendan against Liver Peroxidative Injuries
Elena Grossini, Azienda Ospedaliera Universitaria Maggiore della Carità, Novara, Italy

The uPA / uPAR system contributes to the development of the metabolic syndrome and non-alcoholic fatty liver disease

Nicole Paland, Rambam Health Care Campus, Haifa, Israel

More speakers will be added soon...



infiltrating Monocyte-Derived Macrophages And Resident Kupffer Cells Display Different Ontogeny And Functions In Acute Liver Injury

Share this post

Targeting Liver Diseases





BMS logo


Janssen Cons RGB

At your Diary!


RSS feed